EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseOpen Access · CC BY 4.0

Updated therapeutic options for human brucellosis: A systematic review and network meta-analysis of randomized controlled trials

Shanjun Huang, Jiaying Xu, Hao Wang, Zhuo Li, Ruifang Song, Yiting Zhang, Menghan Lu, Xin Han, Tian Ma, Yingtong Wang, Jiaxin Hao, Shanshan Song und 2 weitere

PLOS Neglected Tropical Diseases · 22.08.2024 · 18 (8) · e0012405

DOI: 10.1371/journal.pntd.0012405 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift PLOS Neglected Tropical Diseases, online erschienen am 22.08.2024. Verfasst von Shanjun Huang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun…. Hauptthemen laut MEDLINE: Brucellosis, Randomized Controlled Trials as Topic, Anti-Bacterial Agents. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In clinical practice guidelines, there is no consensus about the medications that should be initially offered to patients with brucellosis. To provide informative evidence, we compared and ranked brucellosis medications based on their efficacy and safety.

Methods

For this systematic review and network meta-analysis, we searched 4 English databases and 3 Chinese databases, from the date of database inception to December 13, 2023. We included randomized controlled trials (RCTs) involving children and adolescents with brucellosis, comparing different antibiotic regimens. We excluded studies explicitly targeting patients with spondylitis brucellosis, endocarditis brucellosis, and neuro-brucellosis. The primary outcomes were overall failure (efficacy) and side effects (safety). Secondary outcomes were relapse and therapeutic failure. Pairwise meta-analysis was first examined. Data were analyzed using random effects network meta-analysis, with subgroup and sensitivity analyses performed. The Confidence in Network Meta-Analysis (CINeMA) framework was used to assess the certainty of evidence. The protocol was preregistered in PROSPERO (CRD42023491331).

Results

Of the 11,747 records identified through the database search, 43 RCTs were included in the network meta-analysis. Compared with standard therapy (Doxycycline + Rifampicin), Rifampicin + Tetracyclines (RR 4.96; 95% CI 1.47 to 16.70; very low certainty of evidence), Doxycycline + TMP/SMX (RR 0.18; 95% CI 0.06 to 0.52; low certainty of evidence), Doxycycline + Quinolones (RR 0.27; 95% CI 0.11 to 0.71; low certainty of evidence), Streptomycin + Tetracyclines (RR 0.04; 95% CI 0.01 to 0.16; low certainty of evidence), and Single (RR 0.05; 95% CI 0.02 to 0.16; moderate certainty of evidence) were less efficacious. Doxycycline + Gentamicin ranked the best in efficacy (SUCRA values: 0.94), the second is Triple (SUCRA values: 0.87), and the third is Doxycycline + Streptomycin (SUCRA values: 0.78).

Conclusions

Brucellosis medications differ in efficacy and safety. Doxycycline + Gentamicin, Triple, and Doxycycline + Streptomycin have superior efficacy and safety. Treatment of brucellosis should strike a balance between efficacy, safety, and cost.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrucellosisRandomized Controlled Trials as TopicAnti-Bacterial AgentsHumansDoxycyclineAdolescentChildStreptomycinRifampinDrug Therapy, Combination

Substanzen

Anti-Bacterial AgentsDoxycyclineStreptomycinRifampin

Autor:innen und Institutionen

  • Department of Epidemiology and Biostatistics, Key Laboratory of Zoonosis, Ministry of Education, School of Public Health, Jilin University, Changchun, Jilin, PR China.
  • The Second Hospital of Dalian Medical University.
  • State Key Laboratory for Diagnosis and Treatment of Severe Zoonotic Infectious Diseases, Changchun, China.
  • Yunnan Center for Disease Control and Prevention, Kunming, Yunnan, China.

ORCID-Profile: Qing Zhen

Zitieren

APA

Huang, S., Xu, J., Wang, H., Li, Z., Song, R., Zhang, Y., Lu, M., Han, X., Ma, T., Wang, Y., Hao, J., Song, S., Zhen, Q., & Shui, T. (2024). Updated therapeutic options for human brucellosis: A systematic review and network meta-analysis of randomized controlled trials. PLOS Neglected Tropical Diseases, 18(8), e0012405. https://doi.org/10.1371/journal.pntd.0012405

Vancouver

Huang S, Xu J, Wang H, Li Z, Song R, Zhang Y, et al. Updated therapeutic options for human brucellosis: A systematic review and network meta-analysis of randomized controlled trials. PLOS Neglected Tropical Diseases. 2024;18(8):e0012405. doi:10.1371/journal.pntd.0012405

BibTeX
@article{Huang2024,
  author = {Huang, Shanjun and Xu, Jiaying and Wang, Hao and Li, Zhuo and Song, Ruifang and Zhang, Yiting and Lu, Menghan and Han, Xin and Ma, Tian and Wang, Yingtong and Hao, Jiaxin and Song, Shanshan and Zhen, Qing and Shui, Tiejun},
  title = {Updated therapeutic options for human brucellosis: A systematic review and network meta-analysis of randomized controlled trials},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2024},
  volume = {18},
  number = {8},
  pages = {e0012405},
  doi = {10.1371/journal.pntd.0012405}
}
Kostenlos starten →